ReferIndia News Bracing for a flood of semaglutide generics, Novo holds the price line

ReferIndia News

Sponsored

Easy Steps, Real Earnings

Start Earning
News Image

Bracing for a flood of semaglutide generics, Novo holds the price line

Published on: March 17, 2026, 7:33 p.m. | Source: Business Standard

Generic Semaglutide: Novo Nordisk says competition in semaglutide will be driven by science and quality, not pricing, as multiple generic versions prepare to enter India after patent expiry

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact